MC1618A1 - Steroides - Google Patents

Steroides

Info

Publication number
MC1618A1
MC1618A1 MC841722A MC1722A MC1618A1 MC 1618 A1 MC1618 A1 MC 1618A1 MC 841722 A MC841722 A MC 841722A MC 1722 A MC1722 A MC 1722A MC 1618 A1 MC1618 A1 MC 1618A1
Authority
MC
Monaco
Prior art keywords
steroids
Prior art date
Application number
MC841722A
Other languages
English (en)
French (fr)
Inventor
Jean-Marie Cassal
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC1618A1 publication Critical patent/MC1618A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MC841722A 1983-08-25 1984-08-23 Steroides MC1618A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH464483 1983-08-25

Publications (1)

Publication Number Publication Date
MC1618A1 true MC1618A1 (fr) 1985-07-18

Family

ID=4279973

Family Applications (1)

Application Number Title Priority Date Filing Date
MC841722A MC1618A1 (fr) 1983-08-25 1984-08-23 Steroides

Country Status (21)

Country Link
US (1) US4680290A (xx)
EP (1) EP0135762B1 (xx)
JP (1) JPS6061595A (xx)
KR (1) KR850001767A (xx)
AR (1) AR240834A1 (xx)
AT (1) ATE37883T1 (xx)
AU (1) AU574706B2 (xx)
CA (1) CA1252778A (xx)
DE (1) DE3474552D1 (xx)
DK (1) DK347584A (xx)
ES (2) ES535391A0 (xx)
FI (1) FI842830A (xx)
GR (1) GR80196B (xx)
HU (1) HU189929B (xx)
IL (1) IL72725A (xx)
MC (1) MC1618A1 (xx)
NO (1) NO161679C (xx)
NZ (1) NZ209275A (xx)
PH (1) PH19849A (xx)
PT (1) PT79130B (xx)
ZA (1) ZA846430B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1241947A (en) * 1985-05-31 1988-09-13 Pierre R. Proulx Conjugated polyene sterol derivatives as membrane probes
US4946834A (en) * 1988-12-23 1990-08-07 Smithkline Beecham Corporation Phosphonic acid substituted steroids as steroid 5α-reductase inhibitors
US5026882A (en) * 1988-12-23 1991-06-25 Smithkline Beecham Corporation Phosphinic acid substituted steroids as inhibitors of steroid 5α-reductase
US5215972A (en) * 1989-11-22 1993-06-01 Hoffmann-La Roche Inc. Steroids
CA2028759A1 (en) * 1989-11-22 1991-05-23 Jean-Marie Cassal Steroids
US5244887A (en) * 1992-02-14 1993-09-14 Straub Carl D Stanols to reduce cholesterol absorption from foods and methods of preparation and use thereof
JPH10509976A (ja) * 1994-11-30 1998-09-29 アムール リサーチ コーポレーション ホスホコリン薬物誘導体
US5958901A (en) * 1995-06-07 1999-09-28 Genta Incorporated Phosphonic acid-based cationic lipids
CA2223088A1 (en) 1995-06-07 1996-12-19 Bob Dale Brown Novel carbamate-based cationic lipids
EP0948341A4 (en) * 1996-09-17 2003-05-21 Supergen Inc DERIVATIVES OF PHOSPHOLIPIDIC DRUGS
US5830432A (en) * 1997-03-31 1998-11-03 Amur Pharmacuticals, Inc. Phospholipid drug derivatives
CA2330611A1 (en) 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
MXPA02007248A (es) 2000-01-28 2002-12-09 Procter & Gamble Compuestos de arginina con sabor aceptable y usos de los mismos para la salud cardiovascular.
US20030045473A1 (en) * 2002-07-19 2003-03-06 Sarama Robert Joseph Compositions, kits, and methods for cardiovascular health
CA2789262C (en) 2005-04-28 2016-10-04 Proteus Digital Health, Inc. Pharma-informatics system
WO2007035716A2 (en) 2005-09-16 2007-03-29 Raptor Pharmaceutical Inc. Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
EP2097081A1 (en) * 2006-12-08 2009-09-09 Jado Technologies GmbH Cholesterylamines for the treatment and prevention of infectious diseases
PL2398500T3 (pl) 2009-02-20 2019-09-30 2-Bbb Medicines B.V. System dostarczania leków na bazie glutationu
KR101741629B1 (ko) 2009-05-06 2017-05-31 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
WO2023122075A1 (en) * 2021-12-20 2023-06-29 Ohio State Innovation Foundation Compositions comprising sterol-amino-phosphate compounds and methods of making and use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3248408A (en) * 1963-07-22 1966-04-26 Merck & Co Inc Purification of steroid phosphates

Also Published As

Publication number Publication date
PT79130A (en) 1984-09-01
NO161679C (no) 1989-09-13
NO161679B (no) 1989-06-05
NO843406L (no) 1985-02-26
EP0135762A3 (en) 1986-01-22
FI842830A (fi) 1985-02-26
KR850001767A (ko) 1985-04-01
IL72725A (en) 1988-07-31
DE3474552D1 (en) 1988-11-17
HU189929B (en) 1986-08-28
ES8602844A1 (es) 1985-12-01
ZA846430B (en) 1985-04-24
AR240834A2 (es) 1991-02-28
AU3222584A (en) 1985-02-28
IL72725A0 (en) 1984-11-30
US4680290A (en) 1987-07-14
NZ209275A (en) 1987-06-30
ES535391A0 (es) 1985-12-01
DK347584A (da) 1985-02-26
GR80196B (en) 1985-01-02
ATE37883T1 (de) 1988-10-15
FI842830A0 (fi) 1984-07-13
ES543646A0 (es) 1986-05-01
EP0135762A2 (de) 1985-04-03
CA1252778A (en) 1989-04-18
ES8606879A1 (es) 1986-05-01
AR240834A1 (es) 1991-02-28
EP0135762B1 (de) 1988-10-12
JPS6061595A (ja) 1985-04-09
PH19849A (en) 1986-07-22
AU574706B2 (en) 1988-07-14
HUT34997A (en) 1985-05-28
DK347584D0 (da) 1984-07-13
PT79130B (en) 1986-11-14

Similar Documents

Publication Publication Date Title
DK607883A (da) Haandvaegt
FI834098A0 (fi) Foensterloesning
DK347584A (da) Steroider
FI831447A0 (fi) Locktaong
DE3463268D1 (de) 3-oxaprostaglandins
ATA28284A (de) Loetstation
DK23984A (da) D-homosteroider
DK299285A (da) Formeanlaeg
DE3461472D1 (de) Organoclay-antiozonant complex
AT386759B (de) Schlagmuehle
DK571984D0 (da) Skovhoester
FI833433A0 (fi) Skiktkonstruktion
DK525984A (da) Hejsevaerk
DK5284D0 (da) Penemestere
FI832367A0 (fi) Hopmonterbart skivelement
ES535054A0 (es) Imidazotiadiazolalquencarboxiamidas
ATA224283A (de) Kronenstein
FI834052A0 (fi) Seismisk pulsgenerator foer borrhaol
IT1162916B (it) Pannello interparete
BR6300179U (pt) Conjunto
BR6301171U (pt) Conjunto persiana-janela
BR6301779U (pt) Conjunto copo-base
RO87626A2 (ro) Desprafuitor local
SE8306978D0 (sv) Ryggsmorjaren ll
DK150315C (da) Haegtelukke

Legal Events

Date Code Title Description
YP Annual fee paid